Cantitate/Preț
Produs
Total produse
Vezi coșul
Emerging Cancer Therapy – Microbial Approaches and Biotechnological Tools de A Fialho

Emerging Cancer Therapy – Microbial Approaches and Biotechnological Tools: Wiley Series in Biotechnology and Bioengineering

Autor A Fialho
en Limba Engleză Hardback – 15 iul 2010
Cancer therapy remains a challenge despite the huge changes and improvements we have made in the scientific and engineering tools that we use. Emerging Cancer Therapy explores the potential and actual uses of live bacteria or their products in the treatment of cancer. Providing a state-of-the-art overview of this field, this book breaks new ground in emerging cancer treatment modalities. Microbes that are currently and can potentially be used therapeutically and their products are reviewed in detail, and studies involving clinical trials and evaluation with these anticancer agents are addressed.
Citește tot Restrânge

Din seria Wiley Series in Biotechnology and Bioengineering

  • 9% Quality by Design for Biopharmaceuticals – Principles and Case Studies
    Preț: 90566 lei
  • 5% Vaccine Development and Manufacturing
    Preț: 95352 lei
  • 9% Risk Management Applications in Pharmaceutical and Biopharmaceutical Manufacturing
    Preț: 80556 lei

Preț: 98099 lei

Preț vechi: 103262 lei
-5% Nou

Puncte Express: 1471
Preț estimativ în valută:
18774€ • 19501$ • 15595£

Carte tipărită la comandă

Livrare economică 03-17 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780470444672
ISBN-10: 0470444673
Pagini: 448
Dimensiuni: 165 x 234 x 29 mm
Greutate: 0.79 kg
Editura: Wiley
Seria Wiley Series in Biotechnology and Bioengineering

Locul publicării:Hoboken, United States

Public țintă

Biotechnologists and microbiologists in academia and industry, academic and clinical oncologists, medicinal chemists, biochemists and biological chemists in anticancer drug discovery and development.

Cuprins

Notă biografică

ARSÉNIO FIALHO, PhD, is Associate Professor in the Department of Chemical and Biological Engineering and Principal Investigator for the Institute of Biotechnology and Bioengineering in the Instituto Superior Técnico at the Universidade Técnica de Lisboa, Portugal. His current scientific interests are focused on the study of bacterial proteins, such as azurin and Laz, as novel multi-targeted drug candidates with anticancer activities. He is the author or coauthor of more than fifty papers in peer-reviewed scientific journals and, during the last four years, became the holder of five U.S. patents. Dr. Fialho teaches courses in biochemistry, molecular biology, and bioinformatics. ANANDA CHAKRABARTY, PhD, is Distinguished University Professor in the Department of Microbiology and Immunology at the University of Illinois College of Medicine at Chicago. In addition to more than 250 research publications, he has secured nine U.S. patents during the last four years on azurin and Laz, two bacterial proteins with anticancer, anti-viral and anti-parasitic activities. He also is the recipient of a patent on the first life form, a genetically manipulated pseudomonad designed to degrade multiple hydrocarbons present in crude oil, as decided by the U.S. Supreme Court in 1980 in the celebrated court case Diamond v. Chakrabarty.

Descriere

Cancer therapy remains a challenge despite the huge changes and improvements we have made in the scientific and engineering tools that we use. Emerging Cancer Therapy explores the potential and actual uses of live bacteria or their products in the treatment of cancer.